Skip to main content

International Psoriasis Council

International Psoriasis Council
subscribe
4   What's New
Search
subscribe
Search

Advancing Knowledge. Improving Care.

Filip

Rob

,

MD, PhD

Charles University
Prague
,
Czech Republic
2018 Fellow
Councilor Since: September 8, 2022
IPC Councilor
Request an Update
Dr. Rob is the head of the Dermatovenereology Department at the Second Faculty of Medicine, Charles University, University Hospital Bulovka, Prague, Czech Republic. Dr. Rob is published as the lead author on 20 manuscripts dealing with psoriasis and is leading research related to HPV and psoriasis as well as skin and gut microbiota changes in psoriasis patients on biologics.

As a 2018 Fellow, he studied with Dr. Joel Gelfand, MD, MSCE, at the University of Pennsylvania and attended the 27th European Academy of Dermatology and Venereology (EADV) Congress in Paris. While in Philadelphia, he shadowed Prof. Gelfand in his outpatient clinic for patients with psoriasis and attended his research team meetings and other events organized by the department. He was exposed to research cardiovascular comorbidities in psoriasis and their management, advanced phototherapy, and pragmatic clinical trials in psoriasis.
Last Updated:
07/27/2022

IPC Committees / Groups

Disease Severity Working Group
Recent publications

Featured

PDF

Establishing Consensus on Defining Failure of Topical Therapy in Psoriasis: Recommendations from the International…

Early and effective treatment in psoriasis mitigates cumulative chronic disease burden and may prevent psoriatic…

View Report

Blog

Shining a Spotlight: Catching up with 2018 IPC Fellow Filip Rob, MD, PhD.

Catch up with 2018 IPC Fellow Dr. Filip Rob as he shares insights into his experience, achievements, and challenges…

Read More

Video

Psoriasis in People Living with HIV.

Dr. Rob reviews the current as well as novel approach to treating patients with both HIV and psoriasis.

Watch Video

Blog

Meet Our Newest Councilors.

IPC is pleased to introduce and welcome our five newest Councilors for 2022: Pravit Asawanonda, Sunil Dogra, Benjamin…

Read More

Blog

Commentary: Deucravacitinib Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Efficacy and Safety…

The United States Food and Drug Administration (FDA) has approved deucravacitinib to treat psoriasis. Recently, 52-week…

Read More

What's New

Psoriasis: An Expert Global Perspective Is Now Available for Pre-Order

IPC Board Member and Treasurer Joel Gelfand, MD, MSCE, is the editor of a new textbook, Psoriasis: An Expert Global Perspective, now available for preorder from Elsevier. He worked with associate editors IPC President Bruce Strober, MD, PhD; IPC Vice President/President-Elect Claudia de la Cruz, MD; and IPC Chief Medical Officer Peter van de Kerkhof, MD, PhD. Nearly 50 authors from 20 countries contributed 30 chapters covering psoriasis from its earliest descriptions through genetics, immunology, and current therapies, with clinical images of psoriasis across diverse skin tones. All royalties support IPC.

PRE-ORDER YOUR COPY

Thursday, September 10, 2026

New Video Resource: Early Diagnosis and Treatment of Psoriatic Arthritis (PsA)

In this video, IPC Councilor Rodrigo Garcia Salinas, MD, a rheumatologist from Argentina, explains how to recognize psoriatic arthritis early, including why joint pain, how long a patient has had psoriasis, and family history can matter more than skin severity alone. He also reviews how imaging helps catch early disease and how to choose treatment based on each patient’s joint, spine, and skin involvement.

WATCH NOW

Friday, September 25, 2026

Take Ten Video: Bridging Psoriasis and Metabolic Comorbidities

IPC President Bruce Strober reviews the link between psoriasis and metabolic disease, drawing on findings from IPC’s recent paper in the Journal of the American Academy of Dermatology (JAAD). He translates this growing body of evidence into five concrete priorities from the 2025 IPC Think Tank for improving cardiometabolic screening and care.

WATCH NOW

Wednesday, September 9, 2026